Abstract:Nicotinamide adenine dinucleotide (NAD+) is the fundamental molecule that performs numerous biological reactions and is crucial for maintaining cellular homeostasis. Studies have found that NAD+ decreases with age in certain tissues, and age-related NAD+ depletion affects physiological functions and contributes to various aging-related diseases. Supplementation of NAD+ precursor significantly elevates NAD+ levels in murine tissues, effectively mitigates metabolic syndrome, enhances cardiovascular health, protects against neurodegeneration, and boosts muscular strength. Despite the versatile therapeutic functions of NAD+ in animal studies, the efficacy of NAD+ precursors in clinical studies have been limited compared with that in the pre-clinical study. Clinical studies have demonstrated that NAD+ precursor treatment efficiently increases NAD+ levels in various tissues, though their clinical proficiency is insufficient to ameliorate the diseases. However, the latest studies regarding NAD+ precursors and their metabolism highlight the significant role of gut microbiota. The studies found that orally administered NAD+ intermediates interact with the gut microbiome. These findings provide compelling evidence for future trials to further explore the involvement of gut microbiota in NAD+ metabolism. Also, the reduced form of NAD+ precursor shows their potential to raise NAD+, though preclinical studies have yet to discover their efficacy. This review sheds light on NAD+ therapeutic efficiency in preclinical and clinical studies and the effect of the gut microbiota on NAD+ metabolism.

Spectrophotometric determination of the stability of clavulanic acid and its ether and amine derivatives in serum and urine.

Nicotinamide Mononucleotide Improves the Alzheimer's Disease by Regulating Intestinal Microbiota

Regulation of and challenges in targeting NAD + metabolism

Advances in the Synthesis and Physiological Metabolic Regulation of Nicotinamide Mononucleotide

Nicotinamide Mononucleotide Supplementation: Understanding Metabolic Variability and Clinical Implications

The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update

The role of nicotinamide mononucleotide (NMN) in anti-aging, longevity, and its potential for treating chronic conditions

Precursor comparisons for the upregulation of nicotinamide adenine dinucleotide. Novel approaches for better aging

Technology and functional insights into the nicotinamide mononucleotide for human health

Implications of altered NAD metabolism in metabolic disorders

Supplementation with NAD+ Precursors for Treating Alzheimer's Disease: A Metabolic Approach

Nicotinamide Riboside, a Promising Vitamin B3 Derivative for Healthy Aging and Longevity: Current Research and Perspectives

The therapeutic perspective of NAD+ precursors in age-related diseases

Nicotinamide Mononucleotide: Research Process in Cardiovascular Diseases

Comment on: “Anxiety and depression in patients with advanced ovarian cancer: a prospective study”

Advancements in NMN biotherapy and research updates in the field of digestive system diseases

Nicotinamide, Nicotinamide Riboside and Nicotinic Acid—Emerging Roles in Replicative and Chronological Aging in Yeast

NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells

Nicotinamide mononucleotide (NMN) as an anti-aging health product – Promises and safety concerns

Reduced Nicotinamide Mononucleotide (NMNH) Potently Enhances NAD+ and Suppresses Glycolysis, the TCA Cycle, and Cell Growth

Towards personalized nicotinamide mononucleotide (NMN) supplementation: nicotinamide adenine dinucleotide (NAD) concentration